A Pharmacokinetic and Bioavailability Study of Ecklonia cava Phlorotannins Following Intravenous and Oral Administration in Sprague–Dawley Rats
Marine Drugs · 04.11.2024 · 22 (11) · 500
DOI: 10.3390/md22110500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 04.11.2024. Verfasst von Hyeon-Cheol Shin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Phloronol Inc., 490 Post Street, Suite 1700, San Francisco, CA 94102, USA. Hauptthemen laut MEDLINE: Biological Availability, Rats, Sprague-Dawley, Phaeophyceae, Dioxins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Phloronol Inc., Basic Science Research Program through the National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
This study examines the pharmacokinetics and bioavailability of phlorotannins from Ecklonia cava in rats following intravenous and oral administration. Known for their potent antioxidant, anti-inflammatory and many other bioactivities, these phlorotannins, particularly dieckol, 8,8′-bieckol, and phlorofucofuroeckol-A (PFF-A), were analyzed using high-performance liquid chromatography coupled with tandem mass spectrometry. Intravenous administration at 10 mg/kg allowed detectability in plasma for up to 36 h for dieckol and 8,8′-bieckol, but only 2 h for PFF-A. Oral administration at doses of 100 mg/kg and 1000 mg/kg showed limited detectability, indicating low bioavailability and rapid clearance, particularly for PFF-A. The pharmacokinetic data suggest non-linear increases in the maximum plasma concentration (Cmax) and area under the curve (AUC) with increasing doses, pointing to significant challenges in achieving systemic availability of these eckols through oral administration. This study underscores the necessity for advanced formulation strategies and alternative routes of administration to enhance systemic bioavailability. At the same time, this result also suggests their effects may be through non-systemic pathways such as gut microbiome modulation or lipid-rich tissue targeting. The findings lay a crucial foundation for the further development of Ecklonia cava phlorotannins as therapeutic agents, offering insights into their pharmacokinetic behavior and informing enhancements in future clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Phloronol Inc., 490 Post Street, Suite 1700, San Francisco, CA 94102, USA.
- Center for Molecular Intelligence, The State University of New York Korea, Incheon 21985, Republic of Korea.
- MPI Research Inc., 54943 North Main Street, Mattawan, MI 49071, USA.
- Charles River, 54943 North Main Street, Mattawan, MI 49071, USA.
- Aclario Inc., 45600 Terminal Drive, Suite 200, Sterling, VA 20166, USA.
- Botamedi Inc., Cheomdan-ro 8-gil, Jeju 63309, Republic of Korea.
ORCID-Profile: Hyeon-Cheol Shin, Hye Jeong Hwang
Förderung
- National Research Foundation of Korea
- Phloronol Inc.
- Basic Science Research Program through the National Research Foundation of Korea (NRF)
- Ministry of Education
Zitieren
APA
Shin, H. C., Rosenfeld, C., Guttendorf, R. J., Wade, S. B., Park, Y. J., Kim, J. H., Kim, S. H., Lee, B. H., & Hwang, H. J. (2024). A Pharmacokinetic and Bioavailability Study of Ecklonia cava Phlorotannins Following Intravenous and Oral Administration in Sprague–Dawley Rats. Marine Drugs, 22(11), 500. https://doi.org/10.3390/md22110500
Vancouver
Shin HC, Rosenfeld C, Guttendorf RJ, Wade SB, Park YJ, Kim JH, et al. A Pharmacokinetic and Bioavailability Study of Ecklonia cava Phlorotannins Following Intravenous and Oral Administration in Sprague–Dawley Rats. Marine Drugs. 2024;22(11):500. doi:10.3390/md22110500
BibTeX
@article{Shin2024,
author = {Shin, Hyeon-Cheol and Rosenfeld, Clint and Guttendorf, Robert J and Wade, Susan B and Park, Yong Ju and Kim, Ju Hee and Kim, Seong Ho and Lee, Bong Ho and Hwang, Hye Jeong},
title = {A Pharmacokinetic and Bioavailability Study of Ecklonia cava Phlorotannins Following Intravenous and Oral Administration in Sprague–Dawley Rats},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {11},
pages = {500},
doi = {10.3390/md22110500}
}
EUVIMED